Blinatumomab in Adults With Relapsed/Refractory Philadelphia Positive B-precursor Acute Lymphoblastic Leukemia
Clinical trial NCT02000427 · COMPLETED
Trial details
- NCT number
- NCT02000427
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-03
- Primary completion
- 2015-05-20
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.